Literature DB >> 30630646

Inhibition of hsa_circ_0001313 (circCCDC66) induction enhances the radio-sensitivity of colon cancer cells via tumor suppressor miR-338-3p: Effects of cicr_0001313 on colon cancer radio-sensitivity.

Li Wang1, Xiuda Peng2, Xianzhou Lu3, Qinglan Wei4, Mingdao Chen3, Longfei Liu5.   

Abstract

Circular RNA_0001313 (circ_0001313), also known as circCCDC66, is a novel circRNA that recently found to be upregulated in colon cancer tissues and promote colon cancer progression. However, the role of circ_0001313 in regulating radio-sensitivity of colon cancer and its molecular mechanism remain undetermined. Here we found circ_0001313 was significantly upregulated and miR-338-3p was downregulated in radio-resistant colon cancer tissues compared to radio-sensitive tissues. Radiation treatment in colon cells triggered a remarkable upregulation of circ_0001313 and a downregulation of miR-338-3p. Knockdown of circ_0001313 reduced cell viability, colony formation rate and increased caspase-3 activity in colon cancer cells under irradiation. Moreover, circ_0001313 act as a sponge for miR-338-3p in colon cancer cells. Furthermore, miR-338-3p could reverse the effects of circ_0001313 knockdown on cell viability, colony formation, and caspase-3 activity. These findings revealed that knockdown of circ_0001313 could induce radio-sensitivity of colon cancer cells by negatively regulating miR-338-3p.
Copyright © 2019 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Circ_0001313; Colon cancer; Radio-sensitivity; miR-338-3p

Mesh:

Substances:

Year:  2018        PMID: 30630646     DOI: 10.1016/j.prp.2018.12.032

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  29 in total

Review 1.  Circular RNAs: epigenetic regulators in cancerous and noncancerous skin diseases.

Authors:  Abbas Abi; Najmeh Farahani; Ghader Molavi; Seyed Mohammad Gheibi Hayat
Journal:  Cancer Gene Ther       Date:  2019-09-03       Impact factor: 5.987

2.  A study of differential circRNA and lncRNA expressions in COVID-19-infected peripheral blood.

Authors:  Yingping Wu; Tiejun Zhao; Riqiang Deng; Xiaoping Xia; Bin Li; Xunzhang Wang
Journal:  Sci Rep       Date:  2021-04-12       Impact factor: 4.379

3.  Knockdown of Circ_0003506 Impedes Radioresistance, Cell Growth, Migration and Invasion in Gastric Cancer.

Authors:  Kaikai Zhou; Jianwen Zhang; Shunxin Song; Kaihong Xie; Xiaonan Hu
Journal:  Dig Dis Sci       Date:  2022-05-19       Impact factor: 3.199

4.  Circ_0008500 Knockdown Improves Radiosensitivity and Inhibits Tumorigenesis in Breast Cancer Through the miR-758-3p/PFN2 Axis.

Authors:  Deyou Kong; Dongxing Shen; Zhikun Liu; Jun Zhang; Jian Zhang; Cuizhi Geng
Journal:  J Mammary Gland Biol Neoplasia       Date:  2022-03-03       Impact factor: 2.673

5.  Circ_0062020 Knockdown Strengthens the Radiosensitivity of Prostate Cancer Cells.

Authors:  Haitao Li; Yunlai Zhi; Chunyan Ma; Qianqian Shen; Fanghu Sun; Chengkuan Cai
Journal:  Cancer Manag Res       Date:  2020-11-17       Impact factor: 3.989

Review 6.  Circular RNAs: new biomarkers of chemoresistance in cancer.

Authors:  Jiaqi Wang; Yi Zhang; Lianyu Liu; Ting Yang; Jun Song
Journal:  Cancer Biol Med       Date:  2021-03-19       Impact factor: 4.248

7.  Upregulation of circular and linear METTL3 and USP3 in colorectal cancer.

Authors:  Bilal Alkhizzi; Mohammad Imran Khan; Ayat Al-Ghafari; Hani Choudhry
Journal:  Oncol Lett       Date:  2021-07-19       Impact factor: 3.111

Review 8.  Roles of circular RNAs in colorectal cancer.

Authors:  Mingying Zhang; Shubin Wang
Journal:  Oncol Lett       Date:  2021-06-10       Impact factor: 2.967

Review 9.  Functions and mechanisms of circular RNAs in cancer radiotherapy and chemotherapy resistance.

Authors:  Chaochu Cui; Jianbo Yang; Xiao Li; Dongling Liu; Liwu Fu; Xianwei Wang
Journal:  Mol Cancer       Date:  2020-03-14       Impact factor: 27.401

10.  Sevoflurane Suppresses Colon Cancer Cell Malignancy by Regulating circ-PI4KA.

Authors:  Suqing Sun; Peng Wang; Lijie Ren; Hongli Wang; Yanli Zhan; Shimin Shan
Journal:  Onco Targets Ther       Date:  2021-05-20       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.